Cellular collection is an important and increasingly used apheresis procedure. These
collections are performed by leukocytapheresis, a procedure involving the removal of a …

Clinical practice and the technology of cell processing for autologous stem cell
transplantation has continued to evolve over the last two decades and merits review of …

Novel therapies for sickle cell disease (SCD) based on genetically engineered autologous
hematopoietic stem and progenitor cells (HSPCs) are critically dependent on a safe and …

Hematopoietic stem cells can be mobilized from healthy donors using single-agent
plerixafor without granulocyte colony-stimulating factor and, following allogeneic …

Introduction: Collection of peripheral blood stem cells (PBSCs) from healthy donors is a well-
established process. We aimed to identify factors predictive of successful CD34+ PBSC …

Terumo BCT recently introduced a new system for mononuclear cell (MNC) collection that
uses a Spectra Optia apheresis machine equipped with a redesigned disposable kit and …

Background Harvest of more than one CD 34+ stem cell transplant has become the
standard, to ensure the option for a second autologous transplantation in patients with …

Simple Summary We retrospectively reviewed data from cancer patients undergoing
peripheral blood stem cell (PBSC) collection following different mobilization regimens (with …

It has been shown that it is possible to predict the CD 34+ hematopoietic progenitor cell
dose from collection procedures on TerumoBCT COBE Spectra® cell separator platform …

While extensive data demonstrated that plerixafor improves stem cell harvest in difficult‐to‐
mobilize patients, economic concerns limit a broader application. We retrospectively …